Clinical and Molecular Hepatology  2016;22(4):439-442

doi:10.3350/cmh.2016.0108

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?.

Byung Cheol SONG 1

Affiliations

+expand

Keywords

Chronic hepatitis B; Adefovir; Tenofovir; Lamivudine resistance; Suboptimal response

Country

Republic of Korea

Language

English

Abstract

No abstract available.